Surveillance Versus Bronchoscopy After Airway Stenting

ID#: NCT06935695

Age: 18 years - 66+

Gender: All

Healthy Subjects: No

Study Phase: N/A

Recruitment Status: Recruiting

Start Date: January 01, 2025

End Date: March 31, 2026

Contact Information:
Axel Duval, MD
‭(212) 824-8546‬
Summary: Randomized, pilot study that evaluates surveillance bronchoscopy versus no surveillance for patients that undergo tracheobronchial stenting
Eligibility:

Inclusion Criteria:

- All adult patients that undergo central airway (trachea, main stem bronchi and bronchus intermedius) stenting.

Exclusion Criteria:

- Inability to obtain informed consent due to cognitive, neurologic or psychiatric impairment.

- Lobar or segmental stents alone

- Terminally ill patients considered too sick to undergo a follow-up surveillance bronchoscopy

- Stent insertion as a trial for excessive central airway collapse (as the duration of these stents is only 1-2 weeks)

- Patients with a tracheostomy (as these patients can undergo frequent in-line suctioning that can affect the outcomes being assessed)
Find a Clinical Trial Find Cancer Clinical Trials